Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable.

Kasurinen, Jussi; Hagström, Jaana; Kaprio, Tuomas; Beilmann-Lehtonen, Ines; Haglund, Caj; Böckelman, Camilla

Kasurinen, Jussi; Hagström, Jaana; Kaprio, Tuomas; Beilmann-Lehtonen, Ines; Haglund, Caj; Böckelman, Camilla.

Afiliação

Kasurinen J; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Hagström J; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Kaprio T; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Beilmann-Lehtonen I; Department of Oral Pathology and Radiology, University of Turku, Turku, Finland.
Haglund C; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Böckelman C; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Tumour Biol ; 44(1): 37-52, 2022.

Article em En | MEDLINE | ID: mdl-35404299

Assuntos

Neoplasias Colorretais; Linfócitos do Interstício Tumoral; Linfócitos T CD8-Positivos; Neoplasias Colorretais/patologia; Humanos; Estadiamento de Neoplasias; Prognóstico

Palavras-chave

CD3; CD8; T-lymphocytes; colorectal cancer; immunohistochemistry

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Linfócitos do Interstício Tumoral Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Tumour Biol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google